002462 Cachet Pharmaceutical
- 12.24
- +0.18+1.49%
Cachet Pharmaceutical News
Kashitang (002462): the performance is in line with the expected substantial increase in the proportion of major shareholders.
Jiashitang (002462): rapid growth of equipment Wholesale Business and remarkable improvement in operating efficiency
Jiashitang (002462): good performance and rapid development of outport business
Ka Shitang (002462): the performance is in line with the expected outport business to maintain rapid development.
Jiashitang (002462): smooth transition of business in Beijing area and continuous development of business in other areas.
Jiashitang (002462) Quarterly Report Review: Growth in the third quarter was in line with expectations, consumables distribution progressed steadily
Comment on Jiashitang (002462) Quarterly report: the performance is in line with expectations and actively promote the layout of outport business.
Jiashitang (002462): the performance is in line with the expected development momentum of the equipment business.
Jiashitang (002462) quarterly report comments: the third quarter performance growth is good, the company's value is obviously undervalued.
Jiashitang (002462) in-depth study: medical Reform promotes the Integration of Drug Wholesale consumables with clear prospects
Jiashitang (002462) Interim Report: Performance maintained rapid growth in the first half of the year and continued to expand foreign port business
Jiashitang (002462): Second quarter results accelerated epitaxial expansion and integration showed results
Jiashitang (002462) Semi-Annual Report Review: Leading Equipment Distribution, Continued Steady Growth in Performance
Jiashitang (002462) Semi-Annual Report Review: The growth rate is in line with expectations, and the Beijing region has performed well
Commentary on the semi-annual report of Jiashitang (002462): Performance is gradually picking up, and the national layout is progressing steadily
Jiashitang (002462) Semi-Annual Report Review: The Beijing Region Benefits Sunshine Procurement's Steady Expansion Across the Country
Jiashitang (002462) Interim Report: Growth accelerated in the second quarter and the performance of students within half a year was good
Jiashitang (002462) Semi-Annual Report Review: Pharmaceutical Device Dual Wheel Drive Performance Is Growing Rapidly
Jiashitang (002462) Annual Report Review: High Revenue Growth Is Optimistic About National Expansion
Commentary on the 2017 Report and 2018 Quarterly Report of Carshitang (002462): Performance is basically in line with expectations, and outreach expansion continues
Analysis
Price Target
No Data
